Pliant Therapeutics (PLRX) Interest Expenses (2022 - 2025)
Pliant Therapeutics (PLRX) reported Interest Expenses of $136000.0 for Q4 2025, down 83.69% year-over-year from $834000.0 in Q4 2024, and down 83.31% quarter-over-quarter from $815000.0 in Q3 2025.
Pliant Therapeutics (PLRX) Interest Expenses (2022 - 2025) Analysis & Trends
Pliant Therapeutics (PLRX) has 4 years of Interest Expenses data on file, last reported at $136000.0 in Q4 2025.
- Interest Expenses for Q4 2025 came in at $136000.0, down 83.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (down 47.9% YoY), and the FY2025 annual result was $2.6 million, down 15.38% from the prior year.
- Interest Expenses declined to $136000.0 in Q4 2025 per PLRX's latest filing, from $815000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $877000.0 in Q3 2024 and troughed at $136000.0 in Q4 2025.
- A 4-year average of $509466.7 and a median of $321000.0 in 2023 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2024 and 2025: Interest Expenses soared 176.66% in 2024, then slumped 83.69% in 2025.
- A 4-year view of Interest Expenses shows it stood at $317000.0 in 2022, then climbed by 1.26% to $321000.0 in 2023, then soared by 159.81% to $834000.0 in 2024, then tumbled by 83.69% to $136000.0 in 2025.
- Business Quant data shows PLRX's Interest Expenses at $136000.0 in Q4 2025, $815000.0 in Q3 2025, and $809000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -5.58 Mn |
| 10 | Pliant Therapeutics | 74.16 Mn | 74.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 136,000.00 |
| Dec 31, 2025 | 136,000.00 |
| Sep 30, 2025 | 815,000.00 |
| Sep 30, 2025 | 815,000.00 |
| Jun 30, 2025 | 809,000.00 |
| Jun 30, 2025 | 809,000.00 |
| Mar 31, 2025 | 799,000.00 |
| Mar 31, 2025 | 799,000.00 |
| Dec 31, 2024 | 834,000.00 |
| Dec 31, 2024 | 834,000.00 |
| Sep 30, 2024 | 877,000.00 |
| Sep 30, 2024 | 877,000.00 |
| Jun 30, 2024 | 868,000.00 |
| Jun 30, 2024 | 868,000.00 |
| Mar 31, 2024 | 445,000.00 |
| Mar 31, 2024 | 445,000.00 |
| Dec 31, 2023 | 321,000.00 |
| Dec 31, 2023 | 321,000.00 |
| Sep 30, 2023 | 317,000.00 |
| Sep 30, 2023 | 317,000.00 |